CLINICAL AND PROPHYLACTIC DETERMINANTS OF COMORBID DISEASES IN METABOLIC SYNDROME

Metabolic syndrome (MetS) is a cluster of interrelated metabolic abnormalities, including obesity, hypertension, dyslipidemia, and insulin resistance, which significantly increase the risk of cardiovascular diseases, type 2 diabetes, and other comorbid conditions. This article explores the clinical and prophylactic determinants of comorbid diseases in MetS, emphasizing the importance of early diagnosis, lifestyle modifications, and targeted therapeutic interventions. The interplay of genetic, environmental, and behavioral factors contributes to the development and progression of MetS and its associated comorbidities. Effective management strategies, including dietary changes, physical activity, pharmacological treatments, and patient education, are critical in reducing the burden of MetS and improving patient outcomes. This article highlights the need for a multidisciplinary approach to address the complex nature of MetS and its comorbidities, aiming to enhance preventive and therapeutic measures.